Canada clears CardioComm HeartCheck ECG pen
The company has translated the language to meet Health Canada requirements for consumer product sales through the assistance of Lionbridge Technologies and modified the original Health Canada application
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.